nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—prostate cancer—Hydrocortisone—atopic dermatitis	0.222	0.388	CpDpCtD
Metoclopramide—CYP11B2—Hydrocortisone—atopic dermatitis	0.147	0.441	CbGbCtD
Metoclopramide—prostate cancer—Dexamethasone—atopic dermatitis	0.135	0.237	CpDpCtD
Metoclopramide—prostate cancer—Betamethasone—atopic dermatitis	0.135	0.237	CpDpCtD
Metoclopramide—CYP11B1—Hydrocortisone—atopic dermatitis	0.0954	0.287	CbGbCtD
Metoclopramide—migraine—Prednisone—atopic dermatitis	0.0788	0.138	CpDpCtD
Metoclopramide—CYP17A1—Dexamethasone—atopic dermatitis	0.0593	0.178	CbGbCtD
Metoclopramide—CYP2D6—Diphenhydramine—atopic dermatitis	0.0133	0.04	CbGbCtD
Metoclopramide—CYP2D6—Loratadine—atopic dermatitis	0.0133	0.04	CbGbCtD
Metoclopramide—CYP2D6—Dexamethasone—atopic dermatitis	0.0046	0.0138	CbGbCtD
Metoclopramide—Hypotension—Loratadine—atopic dermatitis	0.000201	0.00257	CcSEcCtD
Metoclopramide—Asthenia—Dimenhydrinate—atopic dermatitis	0.0002	0.00256	CcSEcCtD
Metoclopramide—Asthenia—Diphenhydramine—atopic dermatitis	0.0002	0.00256	CcSEcCtD
Metoclopramide—Visual impairment—Tacrolimus—atopic dermatitis	0.000199	0.00255	CcSEcCtD
Metoclopramide—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000199	0.00254	CcSEcCtD
Metoclopramide—Rash—Fluocinonide—atopic dermatitis	0.000195	0.0025	CcSEcCtD
Metoclopramide—Dermatitis—Fluocinonide—atopic dermatitis	0.000195	0.00249	CcSEcCtD
Metoclopramide—Insomnia—Loratadine—atopic dermatitis	0.000194	0.00249	CcSEcCtD
Metoclopramide—Headache—Fluocinonide—atopic dermatitis	0.000194	0.00248	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Triamcinolone—atopic dermatitis	0.000193	0.00247	CcSEcCtD
Metoclopramide—Oedema—Fluocinolone Acetonide—atopic dermatitis	0.000193	0.00247	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Methylprednisolone—atopic dermatitis	0.000193	0.00247	CcSEcCtD
Metoclopramide—Flushing—Tacrolimus—atopic dermatitis	0.000192	0.00245	CcSEcCtD
Metoclopramide—Somnolence—Loratadine—atopic dermatitis	0.000191	0.00244	CcSEcCtD
Metoclopramide—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000191	0.00244	CcSEcCtD
Metoclopramide—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000191	0.00244	CcSEcCtD
Metoclopramide—Fatigue—Loratadine—atopic dermatitis	0.000185	0.00237	CcSEcCtD
Metoclopramide—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000184	0.00236	CcSEcCtD
Metoclopramide—Dizziness—Dimenhydrinate—atopic dermatitis	0.000184	0.00236	CcSEcCtD
Metoclopramide—Dizziness—Diphenhydramine—atopic dermatitis	0.000184	0.00236	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisolone—atopic dermatitis	0.000181	0.00232	CcSEcCtD
Metoclopramide—Fluid retention—Prednisone—atopic dermatitis	0.000181	0.00232	CcSEcCtD
Metoclopramide—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.000177	0.00227	CcSEcCtD
Metoclopramide—Feeling abnormal—Loratadine—atopic dermatitis	0.000177	0.00227	CcSEcCtD
Metoclopramide—Rash—Dimenhydrinate—atopic dermatitis	0.000176	0.00225	CcSEcCtD
Metoclopramide—Rash—Diphenhydramine—atopic dermatitis	0.000176	0.00225	CcSEcCtD
Metoclopramide—Dermatitis—Diphenhydramine—atopic dermatitis	0.000176	0.00225	CcSEcCtD
Metoclopramide—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000176	0.00225	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Betamethasone—atopic dermatitis	0.000175	0.00225	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Dexamethasone—atopic dermatitis	0.000175	0.00225	CcSEcCtD
Metoclopramide—Headache—Dimenhydrinate—atopic dermatitis	0.000175	0.00224	CcSEcCtD
Metoclopramide—Headache—Diphenhydramine—atopic dermatitis	0.000175	0.00224	CcSEcCtD
Metoclopramide—Nervousness—Tacrolimus—atopic dermatitis	0.000175	0.00223	CcSEcCtD
Metoclopramide—Muscle spasms—Tacrolimus—atopic dermatitis	0.000173	0.00221	CcSEcCtD
Metoclopramide—Rash—Pimecrolimus—atopic dermatitis	0.00017	0.00218	CcSEcCtD
Metoclopramide—Dermatitis—Pimecrolimus—atopic dermatitis	0.00017	0.00217	CcSEcCtD
Metoclopramide—Body temperature increased—Loratadine—atopic dermatitis	0.00017	0.00217	CcSEcCtD
Metoclopramide—Headache—Pimecrolimus—atopic dermatitis	0.000169	0.00216	CcSEcCtD
Metoclopramide—Tremor—Tacrolimus—atopic dermatitis	0.000168	0.00216	CcSEcCtD
Metoclopramide—Visual disturbance—Dexamethasone—atopic dermatitis	0.000168	0.00215	CcSEcCtD
Metoclopramide—Visual disturbance—Betamethasone—atopic dermatitis	0.000168	0.00215	CcSEcCtD
Metoclopramide—Cardiac arrest—Triamcinolone—atopic dermatitis	0.000167	0.00213	CcSEcCtD
Metoclopramide—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.000166	0.00213	CcSEcCtD
Metoclopramide—Nausea—Dimenhydrinate—atopic dermatitis	0.000166	0.00212	CcSEcCtD
Metoclopramide—Nausea—Diphenhydramine—atopic dermatitis	0.000166	0.00212	CcSEcCtD
Metoclopramide—Agitation—Tacrolimus—atopic dermatitis	0.000165	0.00211	CcSEcCtD
Metoclopramide—Dyspnoea—Mometasone—atopic dermatitis	0.000164	0.0021	CcSEcCtD
Metoclopramide—Leukopenia—Tacrolimus—atopic dermatitis	0.000161	0.00206	CcSEcCtD
Metoclopramide—Nausea—Pimecrolimus—atopic dermatitis	0.00016	0.00205	CcSEcCtD
Metoclopramide—Fatigue—Mometasone—atopic dermatitis	0.000159	0.00203	CcSEcCtD
Metoclopramide—Palpitations—Tacrolimus—atopic dermatitis	0.000159	0.00203	CcSEcCtD
Metoclopramide—Convulsion—Tacrolimus—atopic dermatitis	0.000156	0.00199	CcSEcCtD
Metoclopramide—Hypertension—Tacrolimus—atopic dermatitis	0.000155	0.00199	CcSEcCtD
Metoclopramide—Asthenia—Loratadine—atopic dermatitis	0.000154	0.00197	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Prednisone—atopic dermatitis	0.000153	0.00196	CcSEcCtD
Metoclopramide—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000153	0.00195	CcSEcCtD
Metoclopramide—Anxiety—Tacrolimus—atopic dermatitis	0.000152	0.00195	CcSEcCtD
Metoclopramide—Asthma—Triamcinolone—atopic dermatitis	0.000151	0.00194	CcSEcCtD
Metoclopramide—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000151	0.00194	CcSEcCtD
Metoclopramide—Cardiac arrest—Betamethasone—atopic dermatitis	0.000151	0.00194	CcSEcCtD
Metoclopramide—Bronchospasm—Methylprednisolone—atopic dermatitis	0.000149	0.0019	CcSEcCtD
Metoclopramide—Confusional state—Tacrolimus—atopic dermatitis	0.000148	0.00189	CcSEcCtD
Metoclopramide—Diarrhoea—Loratadine—atopic dermatitis	0.000147	0.00188	CcSEcCtD
Metoclopramide—Oedema—Tacrolimus—atopic dermatitis	0.000147	0.00188	CcSEcCtD
Metoclopramide—Body temperature increased—Mometasone—atopic dermatitis	0.000146	0.00186	CcSEcCtD
Metoclopramide—Tachycardia—Tacrolimus—atopic dermatitis	0.000143	0.00183	CcSEcCtD
Metoclopramide—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000142	0.00182	CcSEcCtD
Metoclopramide—Dizziness—Loratadine—atopic dermatitis	0.000142	0.00182	CcSEcCtD
Metoclopramide—Hypotension—Tacrolimus—atopic dermatitis	0.000137	0.00175	CcSEcCtD
Metoclopramide—Rash—Loratadine—atopic dermatitis	0.000135	0.00173	CcSEcCtD
Metoclopramide—Dermatitis—Loratadine—atopic dermatitis	0.000135	0.00173	CcSEcCtD
Metoclopramide—Headache—Loratadine—atopic dermatitis	0.000135	0.00172	CcSEcCtD
Metoclopramide—Bradycardia—Prednisolone—atopic dermatitis	0.000134	0.00172	CcSEcCtD
Metoclopramide—Insomnia—Tacrolimus—atopic dermatitis	0.000133	0.0017	CcSEcCtD
Metoclopramide—Asthenia—Mometasone—atopic dermatitis	0.000132	0.00169	CcSEcCtD
Metoclopramide—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000132	0.00169	CcSEcCtD
Metoclopramide—Cardiac arrest—Prednisone—atopic dermatitis	0.000132	0.00169	CcSEcCtD
Metoclopramide—Bradycardia—Hydrocortisone—atopic dermatitis	0.000131	0.00168	CcSEcCtD
Metoclopramide—Dyspnoea—Tacrolimus—atopic dermatitis	0.000131	0.00167	CcSEcCtD
Metoclopramide—Somnolence—Tacrolimus—atopic dermatitis	0.00013	0.00167	CcSEcCtD
Metoclopramide—Hallucination—Hydrocortisone—atopic dermatitis	0.000128	0.00164	CcSEcCtD
Metoclopramide—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000128	0.00163	CcSEcCtD
Metoclopramide—Nausea—Loratadine—atopic dermatitis	0.000128	0.00163	CcSEcCtD
Metoclopramide—Visual impairment—Prednisolone—atopic dermatitis	0.000127	0.00163	CcSEcCtD
Metoclopramide—Fatigue—Tacrolimus—atopic dermatitis	0.000126	0.00162	CcSEcCtD
Metoclopramide—Diarrhoea—Mometasone—atopic dermatitis	0.000126	0.00161	CcSEcCtD
Metoclopramide—Bradycardia—Triamcinolone—atopic dermatitis	0.000123	0.00158	CcSEcCtD
Metoclopramide—Bradycardia—Methylprednisolone—atopic dermatitis	0.000123	0.00158	CcSEcCtD
Metoclopramide—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000122	0.00156	CcSEcCtD
Metoclopramide—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000122	0.00156	CcSEcCtD
Metoclopramide—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000121	0.00155	CcSEcCtD
Metoclopramide—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000121	0.00155	CcSEcCtD
Metoclopramide—Hallucination—Methylprednisolone—atopic dermatitis	0.00012	0.00154	CcSEcCtD
Metoclopramide—Visual impairment—Methylprednisolone—atopic dermatitis	0.000117	0.00149	CcSEcCtD
Metoclopramide—Urticaria—Tacrolimus—atopic dermatitis	0.000117	0.00149	CcSEcCtD
Metoclopramide—Rash—Mometasone—atopic dermatitis	0.000116	0.00149	CcSEcCtD
Metoclopramide—Dermatitis—Mometasone—atopic dermatitis	0.000116	0.00149	CcSEcCtD
Metoclopramide—Body temperature increased—Tacrolimus—atopic dermatitis	0.000116	0.00148	CcSEcCtD
Metoclopramide—Headache—Mometasone—atopic dermatitis	0.000115	0.00148	CcSEcCtD
Metoclopramide—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000115	0.00147	CcSEcCtD
Metoclopramide—Bradycardia—Betamethasone—atopic dermatitis	0.000112	0.00143	CcSEcCtD
Metoclopramide—Bradycardia—Dexamethasone—atopic dermatitis	0.000112	0.00143	CcSEcCtD
Metoclopramide—Neutropenia—Prednisone—atopic dermatitis	0.000112	0.00143	CcSEcCtD
Metoclopramide—Erectile dysfunction—Prednisone—atopic dermatitis	0.00011	0.00141	CcSEcCtD
Metoclopramide—Hallucination—Dexamethasone—atopic dermatitis	0.000109	0.0014	CcSEcCtD
Metoclopramide—Hallucination—Betamethasone—atopic dermatitis	0.000109	0.0014	CcSEcCtD
Metoclopramide—Nausea—Mometasone—atopic dermatitis	0.000109	0.0014	CcSEcCtD
Metoclopramide—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000108	0.00138	CcSEcCtD
Metoclopramide—Depression—Prednisone—atopic dermatitis	0.000106	0.00136	CcSEcCtD
Metoclopramide—Visual impairment—Dexamethasone—atopic dermatitis	0.000106	0.00136	CcSEcCtD
Metoclopramide—Visual impairment—Betamethasone—atopic dermatitis	0.000106	0.00136	CcSEcCtD
Metoclopramide—Asthenia—Tacrolimus—atopic dermatitis	0.000105	0.00135	CcSEcCtD
Metoclopramide—Angioedema—Prednisolone—atopic dermatitis	0.000105	0.00134	CcSEcCtD
Metoclopramide—Angioedema—Hydrocortisone—atopic dermatitis	0.000102	0.00131	CcSEcCtD
Metoclopramide—Diarrhoea—Tacrolimus—atopic dermatitis	0.0001	0.00128	CcSEcCtD
Metoclopramide—Convulsion—Prednisolone—atopic dermatitis	9.94e-05	0.00127	CcSEcCtD
Metoclopramide—Hypertension—Prednisolone—atopic dermatitis	9.91e-05	0.00127	CcSEcCtD
Metoclopramide—Bradycardia—Prednisone—atopic dermatitis	9.75e-05	0.00125	CcSEcCtD
Metoclopramide—Convulsion—Hydrocortisone—atopic dermatitis	9.71e-05	0.00124	CcSEcCtD
Metoclopramide—Dizziness—Tacrolimus—atopic dermatitis	9.7e-05	0.00124	CcSEcCtD
Metoclopramide—Hypertension—Hydrocortisone—atopic dermatitis	9.68e-05	0.00124	CcSEcCtD
Metoclopramide—Angioedema—Triamcinolone—atopic dermatitis	9.64e-05	0.00123	CcSEcCtD
Metoclopramide—Angioedema—Methylprednisolone—atopic dermatitis	9.62e-05	0.00123	CcSEcCtD
Metoclopramide—Hallucination—Prednisone—atopic dermatitis	9.53e-05	0.00122	CcSEcCtD
Metoclopramide—Anxiety—Hydrocortisone—atopic dermatitis	9.51e-05	0.00122	CcSEcCtD
Metoclopramide—Oedema—Prednisolone—atopic dermatitis	9.37e-05	0.0012	CcSEcCtD
Metoclopramide—Rash—Tacrolimus—atopic dermatitis	9.25e-05	0.00118	CcSEcCtD
Metoclopramide—Dermatitis—Tacrolimus—atopic dermatitis	9.24e-05	0.00118	CcSEcCtD
Metoclopramide—Headache—Tacrolimus—atopic dermatitis	9.19e-05	0.00118	CcSEcCtD
Metoclopramide—Oedema—Hydrocortisone—atopic dermatitis	9.15e-05	0.00117	CcSEcCtD
Metoclopramide—Convulsion—Triamcinolone—atopic dermatitis	9.14e-05	0.00117	CcSEcCtD
Metoclopramide—Tachycardia—Prednisolone—atopic dermatitis	9.14e-05	0.00117	CcSEcCtD
Metoclopramide—Convulsion—Methylprednisolone—atopic dermatitis	9.12e-05	0.00117	CcSEcCtD
Metoclopramide—Hypertension—Triamcinolone—atopic dermatitis	9.11e-05	0.00117	CcSEcCtD
Metoclopramide—Hypertension—Methylprednisolone—atopic dermatitis	9.09e-05	0.00116	CcSEcCtD
Metoclopramide—Anxiety—Methylprednisolone—atopic dermatitis	8.93e-05	0.00114	CcSEcCtD
Metoclopramide—Tachycardia—Hydrocortisone—atopic dermatitis	8.93e-05	0.00114	CcSEcCtD
Metoclopramide—Flushing—Prednisone—atopic dermatitis	8.89e-05	0.00114	CcSEcCtD
Metoclopramide—Angioedema—Dexamethasone—atopic dermatitis	8.75e-05	0.00112	CcSEcCtD
Metoclopramide—Angioedema—Betamethasone—atopic dermatitis	8.75e-05	0.00112	CcSEcCtD
Metoclopramide—Nausea—Tacrolimus—atopic dermatitis	8.71e-05	0.00112	CcSEcCtD
Metoclopramide—Confusional state—Methylprednisolone—atopic dermatitis	8.67e-05	0.00111	CcSEcCtD
Metoclopramide—Oedema—Triamcinolone—atopic dermatitis	8.61e-05	0.0011	CcSEcCtD
Metoclopramide—Hypotension—Hydrocortisone—atopic dermatitis	8.55e-05	0.00109	CcSEcCtD
Metoclopramide—Insomnia—Prednisolone—atopic dermatitis	8.47e-05	0.00108	CcSEcCtD
Metoclopramide—Tachycardia—Triamcinolone—atopic dermatitis	8.41e-05	0.00108	CcSEcCtD
Metoclopramide—Tachycardia—Methylprednisolone—atopic dermatitis	8.39e-05	0.00107	CcSEcCtD
Metoclopramide—Convulsion—Dexamethasone—atopic dermatitis	8.3e-05	0.00106	CcSEcCtD
Metoclopramide—Convulsion—Betamethasone—atopic dermatitis	8.3e-05	0.00106	CcSEcCtD
Metoclopramide—Insomnia—Hydrocortisone—atopic dermatitis	8.27e-05	0.00106	CcSEcCtD
Metoclopramide—Hypertension—Dexamethasone—atopic dermatitis	8.27e-05	0.00106	CcSEcCtD
Metoclopramide—Hypertension—Betamethasone—atopic dermatitis	8.27e-05	0.00106	CcSEcCtD
Metoclopramide—Anxiety—Dexamethasone—atopic dermatitis	8.13e-05	0.00104	CcSEcCtD
Metoclopramide—Anxiety—Betamethasone—atopic dermatitis	8.13e-05	0.00104	CcSEcCtD
Metoclopramide—Hypotension—Methylprednisolone—atopic dermatitis	8.03e-05	0.00103	CcSEcCtD
Metoclopramide—Fatigue—Hydrocortisone—atopic dermatitis	7.89e-05	0.00101	CcSEcCtD
Metoclopramide—Oedema—Betamethasone—atopic dermatitis	7.82e-05	0.001	CcSEcCtD
Metoclopramide—Oedema—Dexamethasone—atopic dermatitis	7.82e-05	0.001	CcSEcCtD
Metoclopramide—Insomnia—Triamcinolone—atopic dermatitis	7.79e-05	0.000998	CcSEcCtD
Metoclopramide—Insomnia—Methylprednisolone—atopic dermatitis	7.77e-05	0.000995	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisolone—atopic dermatitis	7.72e-05	0.000988	CcSEcCtD
Metoclopramide—Dyspnoea—Triamcinolone—atopic dermatitis	7.68e-05	0.000983	CcSEcCtD
Metoclopramide—Agitation—Prednisone—atopic dermatitis	7.66e-05	0.000981	CcSEcCtD
Metoclopramide—Tachycardia—Betamethasone—atopic dermatitis	7.63e-05	0.000977	CcSEcCtD
Metoclopramide—Tachycardia—Dexamethasone—atopic dermatitis	7.63e-05	0.000977	CcSEcCtD
Metoclopramide—Angioedema—Prednisone—atopic dermatitis	7.62e-05	0.000976	CcSEcCtD
Metoclopramide—Feeling abnormal—Hydrocortisone—atopic dermatitis	7.54e-05	0.000965	CcSEcCtD
Metoclopramide—Urticaria—Prednisolone—atopic dermatitis	7.44e-05	0.000953	CcSEcCtD
Metoclopramide—Fatigue—Triamcinolone—atopic dermatitis	7.43e-05	0.000951	CcSEcCtD
Metoclopramide—Fatigue—Methylprednisolone—atopic dermatitis	7.41e-05	0.000949	CcSEcCtD
Metoclopramide—Hypotension—Dexamethasone—atopic dermatitis	7.3e-05	0.000935	CcSEcCtD
Metoclopramide—Hypotension—Betamethasone—atopic dermatitis	7.3e-05	0.000935	CcSEcCtD
Metoclopramide—Urticaria—Hydrocortisone—atopic dermatitis	7.27e-05	0.00093	CcSEcCtD
Metoclopramide—Body temperature increased—Hydrocortisone—atopic dermatitis	7.23e-05	0.000926	CcSEcCtD
Metoclopramide—Convulsion—Prednisone—atopic dermatitis	7.23e-05	0.000925	CcSEcCtD
Metoclopramide—Hypertension—Prednisone—atopic dermatitis	7.2e-05	0.000922	CcSEcCtD
Metoclopramide—Feeling abnormal—Triamcinolone—atopic dermatitis	7.1e-05	0.000909	CcSEcCtD
Metoclopramide—Feeling abnormal—Methylprednisolone—atopic dermatitis	7.08e-05	0.000907	CcSEcCtD
Metoclopramide—Anxiety—Prednisone—atopic dermatitis	7.08e-05	0.000906	CcSEcCtD
Metoclopramide—Insomnia—Dexamethasone—atopic dermatitis	7.07e-05	0.000905	CcSEcCtD
Metoclopramide—Insomnia—Betamethasone—atopic dermatitis	7.07e-05	0.000905	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisolone—atopic dermatitis	6.9e-05	0.000884	CcSEcCtD
Metoclopramide—Urticaria—Triamcinolone—atopic dermatitis	6.84e-05	0.000876	CcSEcCtD
Metoclopramide—Urticaria—Methylprednisolone—atopic dermatitis	6.83e-05	0.000874	CcSEcCtD
Metoclopramide—Body temperature increased—Triamcinolone—atopic dermatitis	6.81e-05	0.000872	CcSEcCtD
Metoclopramide—Oedema—Prednisone—atopic dermatitis	6.81e-05	0.000871	CcSEcCtD
Metoclopramide—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.74e-05	0.000863	CcSEcCtD
Metoclopramide—Fatigue—Betamethasone—atopic dermatitis	6.74e-05	0.000863	CcSEcCtD
Metoclopramide—Fatigue—Dexamethasone—atopic dermatitis	6.74e-05	0.000863	CcSEcCtD
Metoclopramide—Tachycardia—Prednisone—atopic dermatitis	6.64e-05	0.000851	CcSEcCtD
Metoclopramide—Asthenia—Hydrocortisone—atopic dermatitis	6.56e-05	0.00084	CcSEcCtD
Metoclopramide—Feeling abnormal—Betamethasone—atopic dermatitis	6.44e-05	0.000825	CcSEcCtD
Metoclopramide—Feeling abnormal—Dexamethasone—atopic dermatitis	6.44e-05	0.000825	CcSEcCtD
Metoclopramide—Hypersensitivity—Triamcinolone—atopic dermatitis	6.35e-05	0.000813	CcSEcCtD
Metoclopramide—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.33e-05	0.000811	CcSEcCtD
Metoclopramide—Diarrhoea—Hydrocortisone—atopic dermatitis	6.26e-05	0.000801	CcSEcCtD
Metoclopramide—Urticaria—Dexamethasone—atopic dermatitis	6.21e-05	0.000795	CcSEcCtD
Metoclopramide—Urticaria—Betamethasone—atopic dermatitis	6.21e-05	0.000795	CcSEcCtD
Metoclopramide—Dizziness—Prednisolone—atopic dermatitis	6.19e-05	0.000793	CcSEcCtD
Metoclopramide—Asthenia—Triamcinolone—atopic dermatitis	6.18e-05	0.000791	CcSEcCtD
Metoclopramide—Body temperature increased—Dexamethasone—atopic dermatitis	6.18e-05	0.000791	CcSEcCtD
Metoclopramide—Body temperature increased—Betamethasone—atopic dermatitis	6.18e-05	0.000791	CcSEcCtD
Metoclopramide—Asthenia—Methylprednisolone—atopic dermatitis	6.17e-05	0.00079	CcSEcCtD
Metoclopramide—Insomnia—Prednisone—atopic dermatitis	6.16e-05	0.000788	CcSEcCtD
Metoclopramide—Dizziness—Hydrocortisone—atopic dermatitis	6.05e-05	0.000775	CcSEcCtD
Metoclopramide—Rash—Prednisolone—atopic dermatitis	5.91e-05	0.000756	CcSEcCtD
Metoclopramide—Dermatitis—Prednisolone—atopic dermatitis	5.9e-05	0.000755	CcSEcCtD
Metoclopramide—Diarrhoea—Methylprednisolone—atopic dermatitis	5.88e-05	0.000753	CcSEcCtD
Metoclopramide—Fatigue—Prednisone—atopic dermatitis	5.87e-05	0.000751	CcSEcCtD
Metoclopramide—Headache—Prednisolone—atopic dermatitis	5.87e-05	0.000751	CcSEcCtD
Metoclopramide—Rash—Hydrocortisone—atopic dermatitis	5.77e-05	0.000739	CcSEcCtD
Metoclopramide—Dermatitis—Hydrocortisone—atopic dermatitis	5.76e-05	0.000738	CcSEcCtD
Metoclopramide—Headache—Hydrocortisone—atopic dermatitis	5.73e-05	0.000734	CcSEcCtD
Metoclopramide—Dizziness—Triamcinolone—atopic dermatitis	5.7e-05	0.000729	CcSEcCtD
Metoclopramide—Dizziness—Methylprednisolone—atopic dermatitis	5.68e-05	0.000728	CcSEcCtD
Metoclopramide—Feeling abnormal—Prednisone—atopic dermatitis	5.61e-05	0.000718	CcSEcCtD
Metoclopramide—Asthenia—Betamethasone—atopic dermatitis	5.61e-05	0.000718	CcSEcCtD
Metoclopramide—Asthenia—Dexamethasone—atopic dermatitis	5.61e-05	0.000718	CcSEcCtD
Metoclopramide—Nausea—Prednisolone—atopic dermatitis	5.56e-05	0.000712	CcSEcCtD
Metoclopramide—Nausea—Hydrocortisone—atopic dermatitis	5.43e-05	0.000696	CcSEcCtD
Metoclopramide—Rash—Triamcinolone—atopic dermatitis	5.43e-05	0.000695	CcSEcCtD
Metoclopramide—Dermatitis—Triamcinolone—atopic dermatitis	5.43e-05	0.000695	CcSEcCtD
Metoclopramide—Rash—Methylprednisolone—atopic dermatitis	5.42e-05	0.000694	CcSEcCtD
Metoclopramide—Dermatitis—Methylprednisolone—atopic dermatitis	5.41e-05	0.000693	CcSEcCtD
Metoclopramide—Urticaria—Prednisone—atopic dermatitis	5.41e-05	0.000692	CcSEcCtD
Metoclopramide—Headache—Triamcinolone—atopic dermatitis	5.4e-05	0.000691	CcSEcCtD
Metoclopramide—Headache—Methylprednisolone—atopic dermatitis	5.38e-05	0.000689	CcSEcCtD
Metoclopramide—Body temperature increased—Prednisone—atopic dermatitis	5.38e-05	0.000689	CcSEcCtD
Metoclopramide—Diarrhoea—Dexamethasone—atopic dermatitis	5.35e-05	0.000685	CcSEcCtD
Metoclopramide—Diarrhoea—Betamethasone—atopic dermatitis	5.35e-05	0.000685	CcSEcCtD
Metoclopramide—Dizziness—Dexamethasone—atopic dermatitis	5.17e-05	0.000662	CcSEcCtD
Metoclopramide—Dizziness—Betamethasone—atopic dermatitis	5.17e-05	0.000662	CcSEcCtD
Metoclopramide—Nausea—Triamcinolone—atopic dermatitis	5.12e-05	0.000655	CcSEcCtD
Metoclopramide—Nausea—Methylprednisolone—atopic dermatitis	5.11e-05	0.000654	CcSEcCtD
Metoclopramide—Hypersensitivity—Prednisone—atopic dermatitis	5.01e-05	0.000642	CcSEcCtD
Metoclopramide—Rash—Dexamethasone—atopic dermatitis	4.93e-05	0.000631	CcSEcCtD
Metoclopramide—Rash—Betamethasone—atopic dermatitis	4.93e-05	0.000631	CcSEcCtD
Metoclopramide—Dermatitis—Dexamethasone—atopic dermatitis	4.92e-05	0.00063	CcSEcCtD
Metoclopramide—Dermatitis—Betamethasone—atopic dermatitis	4.92e-05	0.00063	CcSEcCtD
Metoclopramide—Headache—Betamethasone—atopic dermatitis	4.9e-05	0.000627	CcSEcCtD
Metoclopramide—Headache—Dexamethasone—atopic dermatitis	4.9e-05	0.000627	CcSEcCtD
Metoclopramide—Asthenia—Prednisone—atopic dermatitis	4.88e-05	0.000625	CcSEcCtD
Metoclopramide—Diarrhoea—Prednisone—atopic dermatitis	4.66e-05	0.000596	CcSEcCtD
Metoclopramide—Nausea—Dexamethasone—atopic dermatitis	4.64e-05	0.000594	CcSEcCtD
Metoclopramide—Nausea—Betamethasone—atopic dermatitis	4.64e-05	0.000594	CcSEcCtD
Metoclopramide—Dizziness—Prednisone—atopic dermatitis	4.5e-05	0.000576	CcSEcCtD
Metoclopramide—Rash—Prednisone—atopic dermatitis	4.29e-05	0.000549	CcSEcCtD
Metoclopramide—Dermatitis—Prednisone—atopic dermatitis	4.29e-05	0.000549	CcSEcCtD
Metoclopramide—Headache—Prednisone—atopic dermatitis	4.26e-05	0.000546	CcSEcCtD
Metoclopramide—DRD3—G alpha (i) signalling events—CCL5—atopic dermatitis	4.14e-05	0.00237	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	4.13e-05	0.00237	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CCR3—atopic dermatitis	4.12e-05	0.00236	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCL10—atopic dermatitis	4.09e-05	0.00235	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ADSL—atopic dermatitis	4.09e-05	0.00235	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	4.05e-05	0.00232	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—PPARA—atopic dermatitis	4.05e-05	0.00232	CbGpPWpGaD
Metoclopramide—Nausea—Prednisone—atopic dermatitis	4.04e-05	0.000518	CcSEcCtD
Metoclopramide—DRD3—Signaling by GPCR—CCL22—atopic dermatitis	4.03e-05	0.00231	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—GLB1—atopic dermatitis	3.99e-05	0.00229	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCL27—atopic dermatitis	3.95e-05	0.00227	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—STAT6—atopic dermatitis	3.95e-05	0.00226	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CCL5—atopic dermatitis	3.88e-05	0.00222	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCL11—atopic dermatitis	3.87e-05	0.00222	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ADSL—atopic dermatitis	3.83e-05	0.00219	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	3.82e-05	0.00219	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCL11—atopic dermatitis	3.79e-05	0.00217	CbGpPWpGaD
Metoclopramide—HTR4—GPCR ligand binding—CXCL8—atopic dermatitis	3.74e-05	0.00214	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CCR5—atopic dermatitis	3.73e-05	0.00214	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.69e-05	0.00212	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.69e-05	0.00212	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCL10—atopic dermatitis	3.68e-05	0.00211	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—TAC1—atopic dermatitis	3.67e-05	0.00211	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—NPS—atopic dermatitis	3.67e-05	0.00211	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.62e-05	0.00208	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.61e-05	0.00207	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.61e-05	0.00207	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.61e-05	0.00207	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCR3—atopic dermatitis	3.6e-05	0.00207	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL27—atopic dermatitis	3.59e-05	0.00206	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.54e-05	0.00203	CbGpPWpGaD
Metoclopramide—HTR3A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.52e-05	0.00202	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CCL5—atopic dermatitis	3.52e-05	0.00202	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CCR5—atopic dermatitis	3.49e-05	0.002	CbGpPWpGaD
Metoclopramide—DRD3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	3.46e-05	0.00198	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCR3—atopic dermatitis	3.42e-05	0.00196	CbGpPWpGaD
Metoclopramide—HTR3A—Transmembrane transport of small molecules—PPARA—atopic dermatitis	3.36e-05	0.00193	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	3.29e-05	0.00189	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL17—atopic dermatitis	3.22e-05	0.00185	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CCR5—atopic dermatitis	3.17e-05	0.00182	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CCL5—atopic dermatitis	3.17e-05	0.00182	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCR3—atopic dermatitis	3.15e-05	0.00181	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.11e-05	0.00178	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—PPARA—atopic dermatitis	3.1e-05	0.00178	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCR3—atopic dermatitis	3.09e-05	0.00177	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL22—atopic dermatitis	3.08e-05	0.00177	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—TAC1—atopic dermatitis	3.05e-05	0.00175	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NPS—atopic dermatitis	3.05e-05	0.00175	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—PPARA—atopic dermatitis	3.03e-05	0.00174	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCL27—atopic dermatitis	3.02e-05	0.00173	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL22—atopic dermatitis	3.01e-05	0.00173	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCR3—atopic dermatitis	2.99e-05	0.00171	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.96e-05	0.0017	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCL27—atopic dermatitis	2.96e-05	0.0017	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.93e-05	0.00168	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCL10—atopic dermatitis	2.91e-05	0.00167	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.91e-05	0.00167	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.86e-05	0.00164	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CCR5—atopic dermatitis	2.85e-05	0.00164	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL5—atopic dermatitis	2.83e-05	0.00163	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—NPS—atopic dermatitis	2.81e-05	0.00161	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—TAC1—atopic dermatitis	2.81e-05	0.00161	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCR3—atopic dermatitis	2.76e-05	0.00158	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—NPS—atopic dermatitis	2.75e-05	0.00158	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—TAC1—atopic dermatitis	2.75e-05	0.00158	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL27—atopic dermatitis	2.75e-05	0.00157	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCR3—atopic dermatitis	2.7e-05	0.00155	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL27—atopic dermatitis	2.69e-05	0.00154	CbGpPWpGaD
Metoclopramide—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.65e-05	0.00152	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL11—atopic dermatitis	2.59e-05	0.00149	CbGpPWpGaD
Metoclopramide—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.59e-05	0.00149	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FCER2—atopic dermatitis	2.56e-05	0.00147	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.52e-05	0.00144	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CCL5—atopic dermatitis	2.51e-05	0.00144	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.46e-05	0.00141	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL17—atopic dermatitis	2.46e-05	0.00141	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL10—atopic dermatitis	2.42e-05	0.00139	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL17—atopic dermatitis	2.41e-05	0.00138	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL22—atopic dermatitis	2.38e-05	0.00136	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR3—atopic dermatitis	2.33e-05	0.00134	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.27e-05	0.0013	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CCR5—atopic dermatitis	2.26e-05	0.00129	CbGpPWpGaD
Metoclopramide—DRD3—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.25e-05	0.00129	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—MAPK8—atopic dermatitis	2.25e-05	0.00129	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL10—atopic dermatitis	2.23e-05	0.00128	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.22e-05	0.00127	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	2.18e-05	0.00125	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL27—atopic dermatitis	2.12e-05	0.00122	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR3—atopic dermatitis	2.11e-05	0.00121	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—CXCL8—atopic dermatitis	2.11e-05	0.00121	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCL5—atopic dermatitis	2.08e-05	0.00119	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—NPS—atopic dermatitis	2.08e-05	0.00119	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—TAC1—atopic dermatitis	2.08e-05	0.00119	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCR3—atopic dermatitis	2.04e-05	0.00117	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—IL2—atopic dermatitis	2.02e-05	0.00116	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL11—atopic dermatitis	1.99e-05	0.00114	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FCER2—atopic dermatitis	1.96e-05	0.00112	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	1.94e-05	0.00111	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL5—atopic dermatitis	1.93e-05	0.00111	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NGF—atopic dermatitis	1.93e-05	0.00111	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—CXCL8—atopic dermatitis	1.92e-05	0.0011	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCL5—atopic dermatitis	1.92e-05	0.0011	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	1.92e-05	0.0011	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL17—atopic dermatitis	1.9e-05	0.00109	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—NPS—atopic dermatitis	1.88e-05	0.00108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—TAC1—atopic dermatitis	1.88e-05	0.00108	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	1.88e-05	0.00108	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CCR5—atopic dermatitis	1.87e-05	0.00108	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCR3—atopic dermatitis	1.85e-05	0.00106	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL2—atopic dermatitis	1.83e-05	0.00105	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL22—atopic dermatitis	1.82e-05	0.00104	CbGpPWpGaD
Metoclopramide—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.79e-05	0.00103	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR3—atopic dermatitis	1.78e-05	0.00102	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	1.78e-05	0.00102	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL5—atopic dermatitis	1.75e-05	0.00101	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	1.74e-05	0.001	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CCR5—atopic dermatitis	1.73e-05	0.000991	CbGpPWpGaD
Metoclopramide—DRD2—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.73e-05	0.000989	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—MAPK8—atopic dermatitis	1.72e-05	0.000986	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KIF3A—atopic dermatitis	1.69e-05	0.000972	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	1.69e-05	0.00097	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	1.68e-05	0.000965	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL10—atopic dermatitis	1.65e-05	0.000944	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL27—atopic dermatitis	1.62e-05	0.00093	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR3—atopic dermatitis	1.62e-05	0.000928	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PPARA—atopic dermatitis	1.61e-05	0.000922	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—NFKBIA—atopic dermatitis	1.59e-05	0.000911	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—TAC1—atopic dermatitis	1.59e-05	0.000911	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—NPS—atopic dermatitis	1.59e-05	0.000911	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	1.59e-05	0.00091	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	1.58e-05	0.000908	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCR3—atopic dermatitis	1.56e-05	0.000893	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	1.55e-05	0.000892	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	1.55e-05	0.000892	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL11—atopic dermatitis	1.53e-05	0.000879	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CMA1—atopic dermatitis	1.53e-05	0.000879	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.52e-05	0.000874	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL10—atopic dermatitis	1.49e-05	0.000857	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL5—atopic dermatitis	1.48e-05	0.000847	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL17—atopic dermatitis	1.45e-05	0.000834	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	1.45e-05	0.000829	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—TAC1—atopic dermatitis	1.44e-05	0.000827	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—NPS—atopic dermatitis	1.44e-05	0.000827	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—STAT6—atopic dermatitis	1.44e-05	0.000826	CbGpPWpGaD
Metoclopramide—DRD3—Circadian rythm related genes—IL6—atopic dermatitis	1.44e-05	0.000823	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	1.42e-05	0.000817	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCL5—atopic dermatitis	1.42e-05	0.000812	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	1.41e-05	0.000811	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	1.41e-05	0.00081	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	1.41e-05	0.00081	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PPARA—atopic dermatitis	1.38e-05	0.000794	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	1.38e-05	0.000794	CbGpPWpGaD
Metoclopramide—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.37e-05	0.000787	CbGpPWpGaD
Metoclopramide—DRD3—GPCR ligand binding—CXCL8—atopic dermatitis	1.37e-05	0.000783	CbGpPWpGaD
Metoclopramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.34e-05	0.00077	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL5—atopic dermatitis	1.34e-05	0.000769	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	1.31e-05	0.000753	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	1.3e-05	0.000744	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PPARA—atopic dermatitis	1.3e-05	0.000743	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL5—atopic dermatitis	1.29e-05	0.000738	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CCR5—atopic dermatitis	1.28e-05	0.000732	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	1.27e-05	0.000728	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.26e-05	0.000722	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR3—atopic dermatitis	1.25e-05	0.000717	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.23e-05	0.000707	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL11—atopic dermatitis	1.17e-05	0.000673	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CMA1—atopic dermatitis	1.17e-05	0.000673	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCR5—atopic dermatitis	1.16e-05	0.000665	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	1.15e-05	0.000658	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	1.15e-05	0.000658	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	1.14e-05	0.000656	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CXCL8—atopic dermatitis	1.13e-05	0.00065	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	1.12e-05	0.000642	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NPS—atopic dermatitis	1.11e-05	0.000639	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TAC1—atopic dermatitis	1.11e-05	0.000639	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—STAT6—atopic dermatitis	1.1e-05	0.000632	CbGpPWpGaD
Metoclopramide—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	1.1e-05	0.00063	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCR3—atopic dermatitis	1.09e-05	0.000626	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	1.08e-05	0.000622	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL2—atopic dermatitis	1.08e-05	0.000621	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.08e-05	0.000619	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	1.08e-05	0.000619	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—IL6—atopic dermatitis	1.08e-05	0.000618	CbGpPWpGaD
Metoclopramide—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	1.07e-05	0.000616	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	1.06e-05	0.000608	CbGpPWpGaD
Metoclopramide—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	1.04e-05	0.000599	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL5—atopic dermatitis	1.04e-05	0.000594	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.03e-05	0.000594	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	1.02e-05	0.000586	CbGpPWpGaD
Metoclopramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.02e-05	0.000584	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MAPK8—atopic dermatitis	9.97e-06	0.000572	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	9.84e-06	0.000564	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	9.76e-06	0.00056	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	9.63e-06	0.000552	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR3—atopic dermatitis	9.56e-06	0.000548	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	9.56e-06	0.000548	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	9.36e-06	0.000537	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	8.87e-06	0.000509	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	8.83e-06	0.000506	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	8.68e-06	0.000498	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPS—atopic dermatitis	8.52e-06	0.000489	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TAC1—atopic dermatitis	8.52e-06	0.000489	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	8.36e-06	0.000479	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPS—atopic dermatitis	8.34e-06	0.000478	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	8.34e-06	0.000478	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	8.18e-06	0.000469	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL5—atopic dermatitis	7.92e-06	0.000454	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL5—atopic dermatitis	7.75e-06	0.000445	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	7.71e-06	0.000442	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL5—atopic dermatitis	7.6e-06	0.000436	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	7.37e-06	0.000423	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGF—atopic dermatitis	7.04e-06	0.000404	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	7.01e-06	0.000402	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR5—atopic dermatitis	6.84e-06	0.000393	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	6.75e-06	0.000387	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL2—atopic dermatitis	6.69e-06	0.000384	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	6.61e-06	0.000379	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—IL6—atopic dermatitis	6.37e-06	0.000365	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	5.9e-06	0.000339	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL5—atopic dermatitis	5.81e-06	0.000333	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	5.8e-06	0.000333	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.78e-06	0.000331	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	5.69e-06	0.000326	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	5.64e-06	0.000324	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	5.52e-06	0.000317	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGF—atopic dermatitis	5.38e-06	0.000309	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	5.36e-06	0.000307	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGF—atopic dermatitis	5.27e-06	0.000302	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	5.25e-06	0.000301	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR5—atopic dermatitis	5.24e-06	0.0003	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	5.13e-06	0.000294	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL2—atopic dermatitis	5.12e-06	0.000294	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	5.01e-06	0.000288	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	4.44e-06	0.000255	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	4.35e-06	0.000249	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	4.14e-06	0.000237	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL2—atopic dermatitis	3.95e-06	0.000227	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6—atopic dermatitis	3.94e-06	0.000226	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	3.64e-06	0.000209	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.5e-06	0.000201	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	3.17e-06	0.000182	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	3.1e-06	0.000178	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL2—atopic dermatitis	3.03e-06	0.000174	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6—atopic dermatitis	3.01e-06	0.000173	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL2—atopic dermatitis	2.96e-06	0.00017	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	2.95e-06	0.000169	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.79e-06	0.00016	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	2.73e-06	0.000156	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6—atopic dermatitis	2.32e-06	0.000133	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.78e-06	0.000102	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6—atopic dermatitis	1.74e-06	9.98e-05	CbGpPWpGaD
